IRCT2014020213698N1已完成2 期
The Study of the efficacy, safety and tolerability of low molecular weight heparin vs. unfractionated heparin in patients with embolic stroke due to atrial fibrillation
Shiraz University of Medical Scienses0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria:
- •confirmed diagnosis of acute ischemic stroke purely due to AF
- •AF confirmed by ECG or 24 hour holter monitoring
- •Patients who need initiation of anticoagulation for prevention of recurrent stroke
排除标准
- •ages less than 18 or more than 75
- •no cooperation
- •CNS hemorrhage
- •major bleeding
- •infarction size of more than one third of MCA territory
- •NIHS score more than 20
- •hypersensitivity to IV UFH or LMWH
- •no informed consent
- •other causes for stroke except AF
- •breast feeding
- •uncontrolled HTN (BP more than 220/120)
- •renal, hepatic, respiratory or cardiac failure
- •myocardial infarction
- •infectious endocarditis
研究者
相似试验
进行中（未招募）
1 期
A Study to Assess the Efficacy, Safety and Pharmacokinetics of IONIS SMNRx in Infants With Spinal Muscular AtrophySpinal Muscular Atrophy (SMA)EUCTR2017-000621-12-Outside-EU/EEAIonis Pharmaceuticals, Inc.20
尚未招募
2 期
A Study of kultha tea in kidney stoneCTRI/2020/05/025246Ravi Kant
进行中（未招募）
1 期
An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 20.0Level: PTClassification code 10077024Term: Familial amyotrophic lateral sclerosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-004098-33-DKBiogen Idec Research Limited183
进行中（未招募）
1 期
An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 20.0Level: PTClassification code 10077024Term: Familial amyotrophic lateral sclerosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-004098-33-PLBiogen Idec Research Limited183
进行中（未招募）
1 期
An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 20.0Level: PTClassification code 10077024Term: Familial amyotrophic lateral sclerosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.0Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-004098-33-SEBiogen Idec Research Limited144